Benitec Biopharma (BNTC) Operating Expenses (2019 - 2025)
Benitec Biopharma (BNTC) posted Operating Expenses of $13.4 million for Q4 2025, up 36.46% sequentially from $9.8 million in Q3 2025, and up 23.8% YoY from $10.8 million in Q4 2024.
Benitec Biopharma (BNTC) Operating Expenses (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Operating Expenses for 7 years, with the latest figure at $13.4 million in Q4 2025.
- Quarterly Operating Expenses rose 23.8% year-over-year to $13.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $48.3 million (up 83.94% YoY) and the FY2025 annual result came in at $41.8 million, up 85.7% from the prior year.
- Operating Expenses improved to $13.4 million in Q4 2025 per BNTC's latest filing, from $9.8 million in the prior quarter.
- Over five years, Operating Expenses peaked at $15.3 million in Q1 2025 and troughed at $3.5 million in Q1 2022.
- A 5-year average of $6.6 million and a median of $5.2 million in 2021 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses fell 7.54% in 2022, then soared 270.32% in 2025.
- Over 5 years, Operating Expenses stood at $4.9 million in 2021, then climbed by 15.72% to $5.6 million in 2022, then grew by 23.17% to $6.9 million in 2023, then jumped by 55.98% to $10.8 million in 2024, then rose by 23.8% to $13.4 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $13.4 million, $9.8 million, and $9.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | 13.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.38 Mn |
| Sep 30, 2025 | 9.80 Mn |
| Jun 30, 2025 | 9.83 Mn |
| Mar 31, 2025 | 15.34 Mn |
| Dec 31, 2024 | 10.81 Mn |
| Sep 30, 2024 | 5.79 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Mar 31, 2024 | 4.14 Mn |
| Dec 31, 2023 | 6.93 Mn |
| Sep 30, 2023 | 5.87 Mn |
| Jun 30, 2023 | 4.56 Mn |
| Mar 31, 2023 | 4.40 Mn |
| Dec 31, 2022 | 5.62 Mn |
| Sep 30, 2022 | 4.58 Mn |
| Jun 30, 2022 | 4.74 Mn |
| Mar 31, 2022 | 3.51 Mn |
| Dec 31, 2021 | 4.86 Mn |
| Sep 30, 2021 | 4.82 Mn |
| Jun 30, 2021 | 3.86 Mn |
| Mar 31, 2021 | 3.79 Mn |